Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced and Metastatic Solid Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07623642
What this trial is testing

A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.

Who this might be right for
Uterine Cervical NeoplasmsTriple Negative Breast NeoplasmsProstatic Neoplasms+8 more
GV20 Therapeutics 227
Early research (Phase 1)Looking for participantsNCT06069570
What this trial is testing

Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases

Who this might be right for
Carcinoma, Non-Small-Cell Lung CancerBone Metastases From Solid Tumors
Kiromic BioPharma Inc. 48
Early research (Phase 1)Study completedNCT06087770
What this trial is testing

Clinical Study of SM3321 With Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
Beijing StarMab Biomed Technology Ltd 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT06003231
What this trial is testing

Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2

Who this might be right for
Carcinoma, Non-Small-Cell LungOvarian NeoplasmsEndometrial Neoplasms+1 more
Seagen, a wholly owned subsidiary of Pfizer 120
Testing effectiveness (Phase 2)Looking for participantsNCT05706129
What this trial is testing

Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Clear Cell Renal Cell Cancer (ccRCC)Pancreatic Ductal Adenocarcinoma (PDAC)Colorectal Cancer (CRC)+6 more
Lumara Bio Oncologics GmbH 270
Early research (Phase 1)Study completedNCT02304393
What this trial is testing

Selicrelumab (RO7009789) in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
Hoffmann-La Roche 140
Early research (Phase 1)Study completedNCT04672434
What this trial is testing

Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Metastatic CancerSolid Tumor
Symphogen A/S 48
Testing effectiveness (Phase 2)Looking for participantsNCT04996121
What this trial is testing

XZP-5955 Tablets in Patients With NTRK or ROS1 Fusion Positive Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid TumorsLocally Advanced or Metastatic Non-small Cell Lung Cancer
Xuanzhu Biopharmaceutical Co., Ltd. 360
Early research (Phase 1)Looking for participantsNCT05607498
What this trial is testing

First in Human Study of EMB-07 in Locally Advanced/Metastatic Solid Tumors or Relapse/Refractory Lymphoma

Who this might be right for
Advanced/Metastatic Solid TumorsRelapse/Refractory Lymphoma
EpimAb Biotherapeutics (Suzhou)Co., Ltd. 150
Early research (Phase 1)UnknownNCT03646071
What this trial is testing

RX108 in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced Solid TumorsMetastatic Solid Tumors
NeuPharma, Inc. 80
Early research (Phase 1)Study completedNCT02324257
What this trial is testing

RO6958688 in Participants With Locally Advanced and/or Metastatic Carcinoembryonic Antigen Positive Solid Tumors

Who this might be right for
Solid Tumors
Hoffmann-La Roche 149
Testing effectiveness (Phase 2)Looking for participantsNCT05919264
What this trial is testing

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Who this might be right for
CancerColorectal CancerSolid Tumor+12 more
Parabilis Medicines, Inc. 619
Early research (Phase 1)Study completedNCT02990481
What this trial is testing

Study Evaluating the Safety of TRK-950 in Patients With Advanced Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid CarcinomasColon CancerCholangiocarcinoma
Toray Industries, Inc 38
Early research (Phase 1)Study completedNCT00496028
What this trial is testing

Phase I Study in Patients With Solid Tumours

Who this might be right for
Neoplasms
AstraZeneca 148
Testing effectiveness (Phase 2)Ended earlyNCT04800627
What this trial is testing

Pevonedistat and Pembrolizumab for the Treatment of dMMR/MSI-H Metastatic or Locally Advanced Unresectable Solid Tumor

Who this might be right for
Locally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm
M.D. Anderson Cancer Center 2
Testing effectiveness (Phase 2)Looking for participantsNCT07205718
What this trial is testing

TAK-188 in Adults With Advanced or Spreading Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Takeda 223
Testing effectiveness (Phase 2)Active Not RecruitingNCT05862324
What this trial is testing

TAC T-cells for the Treatment of Claudin 18.2 Positive Solid Tumors (TACTIC-3)

Who this might be right for
Metastatic Solid Tumor
Triumvira Immunologics, Inc. 113
Early research (Phase 1)UnknownNCT06175780
What this trial is testing

Phase I Study of KY-0118 in Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
NeoplasmsNeoplasms by Histologic Type
Novatim Immune Therapeutics (Zhejiang) Co., Ltd. 189
Early research (Phase 1)Study completedNCT02045602
What this trial is testing

Phase I Dose Escalation Study of Intravenous VCN-01 With or Without Gemcitabine and Abraxane® in Patients With Advanced Solid Tumors

Who this might be right for
Locally Advanced Solid TumorsMetastatic Solid TumorsPancreatic Adenocarcinoma
Theriva Biologics SL 42
Early research (Phase 1)Looking for participantsNCT07589205
What this trial is testing

Study of IBI3028 in Participants With Locally Advanced, Unresectable, or Metastatic Solid Tumors

Who this might be right for
Solid TumorColorectal CancerNon-small Cell Lung Cancer+2 more
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. 493
Next Page